Building the Infrastructure for Made‑to‑Order Gene Therapies

RARECast by RARECast

Jul 9, 202600:35:49Business

The case of baby KJ Muldoon, an infant born with a lethal genetic metabolic disorder, demonstrates the potential to compress years of therapeutic development into months using an in vivo base editing approach. Jeff Colle...

Related Episodes

Continue listening to more episodes from RARECast.

Using Exosomes to Tackle the Delivery Challenge of Genetic Medicines for the Brain

Sep 17, 2026 - 00:27:08

Genetic medicine has already begun to transform the treatment of some inherited diseases, but the brain r...

Building a Roadmap to Treat a Rare Neurodevelopmental Condition

Sep 10, 2026 - 00:33:55

Kleefstra syndrome is a rare neurodevelopmental condition with significant unmet medical needs, but a gro...

The Long Road from the NICU to New Therapies

Sep 3, 2026 - 00:52:42

Congenital hyperinsulinism can turn a newborn’s first days into a medical emergency. The body produces to...

Stopping Guillain-Barré Syndrome at Its Source

Aug 27, 2026 - 00:39:13

Guillain-Barré syndrome is a rare, rapidly progressive autoimmune disorder in which harmful inflammation...

From Repeated Surgery to a Precision Patch

Aug 20, 2026 - 00:34:56

People with the rare genetic condition Gorlin syndrome can develop dozens or even hundreds of basal cell...

Curing Sickle Cell Before Life Begins

Aug 13, 2026 - 00:30:56

Sickle cell disease is caused by a single mutation in the beta-globin gene that leads to painful crises,...

Spotting Neuromuscular Red Flags

Aug 6, 2026 - 00:37:08

Many older adults may dismiss dropping objects, struggling with stairs, or tiring on short walks as a mat...

Expanding into a Global Rare Disease Player through Deal-Driven Innovation

Jul 30, 2026 - 00:51:57

Chiesi Global Rare Diseases has rapidly evolved from a small, regional rare‑disease business into a globa...